Updated:
Tar Heel Capital
Tar Heel Capital is a private equity firm managing THC IV, a €120M fund closed and focused on the development of Polish medium-sized enterprises, with...
Tar Heel Capital
Tar Heel Capital is a private equity firm managing THC IV, a €120M fund closed and focused on the development of Polish medium-sized enterprises, with particular emphasis on succession planning by Polish entrepreneurs. The firm operates from offices in Warsaw and Szczecin. Its current portfolio includes a Polish producer of ecological paper packaging, a Polish producer of aluminum components, and a medical center.
General information
Firm type
Private Equity
Year founded
1998
Location
Region
Europe
Country
Poland
City
Warsaw
Corporate office
Warsaw, Poland
Sector focus
Frequently asked questions
What investment strategies does Tar Heel Capital pursue?
Public records describe a multi-strategy approach covering venture capital from seed through late-stage, growth equity, and buyout transactions including management buyouts, divestitures, and corporate restructurings. The firm blends early-stage venture origination with control-oriented private equity, operating across the full company lifecycle.
Where does Tar Heel Capital invest geographically?
Tar Heel Capital is headquartered in Warsaw, Poland, and targets investments across Central Europe. The broader Central European corridor, with its fragmented private markets and succession-driven deal flow, forms the firm's primary geographic focus, though specific country allocations have not been publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: